SRPT vs STE · rev $1.90B vs P/E 25, rev $5.46B
Sarepta Therapeutics Inc (SRPT) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
SRPT currently screens at market cap $2.34B. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the SRPT and STE stock pages for the full models.
Not investment advice.